Clinical Trials
3 trialsNCT05075538 2024-01-17
I-SPARC
Jules Bordet Institute
Phase 4 Terminated
NCT04930055 2023-05-19
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
Indiana University
Terminated
NCT05054218 2023-04-14
COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients
H. Lee Moffitt Cancer Center and Research Institute
Completed